CHEMED CORP

CHEMED CORPCHEEarnings & Financial Report

NYSE · Health Care · Services-Home Health Care Services

LG Chem Ltd., often referred to as LG Chemical, is the largest Korean chemical company and is headquartered in Seoul, South Korea. It was the 9th largest chemical company in the world by sales in 2021. It was first established as the Lucky Chemical Industrial Corporation, which manufactured cosmetics. It is now solely a business-to-business company.

CHE Q1 FY2026 Key Financial Metrics

Revenue

$420.0M

Gross Profit

N/A

Operating Profit

$84.6M

Net Profit

$66.3M

Gross Margin

N/A

Operating Margin

20.1%

Net Margin

15.8%

YoY Growth

3.1%

CHEMED CORP Q1 FY2026 Financial Summary

CHEMED CORP reported revenue of $420.0M (up 3.1% YoY) for Q1 FY2026, with a net profit of $66.3M (15.8% margin).

Key Financial Metrics

Total Revenue$420.0M
Net Profit$66.3M
Gross MarginN/A
Operating Margin20.1%
Report PeriodQ1 FY2026

Revenue Breakdown

CHEMED CORP Q1 FY2026 revenue of $420.0M breaks down across 3 segments, led by Homecare at $371.1M (88.4% of total).

SegmentRevenue% of Total
Homecare$371.1M88.4%
Inpatient$35.9M8.6%
Other$13.0M3.1%

CHEMED CORP Revenue by Segment — Quarterly Trend

CHEMED CORP revenue by segment across the last 4 reported quarters, showing how each business line (such as Homecare and Inpatient) has evolved quarter over quarter.

SegmentQ1 FY2026Q4 FY2025Q3 FY2025Q2 FY2025
Homecare$371.1M
Inpatient$35.9M
Other$13.0M$38.6M$24.0M

CHEMED CORP Annual Revenue by Year

CHEMED CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.5B).

YearAnnual Revenue
2025$2.5Bvs 2024
2024$1.5Bvs 2023
2023$1.3Bvs 2022
2022$1.2B

CHEMED CORP Quarterly Revenue & Net Profit History

CHEMED CORP results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.

QuarterRevenueRevenue YoYNet ProfitNet Margin
Q1 FY2026$420.0M+3.1%$66.3M15.8%
Q4 FY2025$639.3M+55.6%$76.8M12.0%
Q3 FY2025$624.9M+59.7%$64.2M10.3%
Q2 FY2025$618.8M+65.2%$52.5M8.5%
Q1 FY2025$646.9M+82.7%$71.8M11.1%
Q4 FY2024$411.0M+17.4%$90.3M22.0%
Q3 FY2024$391.4M+17.3%$75.8M19.4%
Q2 FY2024$374.6M+16.7%$70.9M18.9%

Income Statement

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Revenue$374.6M$391.4M$411.0M$646.9M$618.8M$624.9M$639.3M$420.0M
YoY Growth16.7%17.3%17.4%82.7%65.2%59.7%55.6%3.1%

Balance Sheet

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Assets$1.73B$1.77B$1.67B$1.73B$1.72B$1.62B$1.54B$1.54B
Liabilities$527.7M$533.7M$549.6M$544.8M$519.4M$546.9M$558.8M$687.8M
Equity$1.21B$1.24B$1.12B$1.18B$1.20B$1.08B$979.4M$848.0M

Cash Flow

Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026
Operating CF$77.5M$90.5M$164.9M$32.7M$138.6M$83.4M$133.5M$88.2M